The Director General of Pharmaceuticals and Medical Devices Visits Fapon in Indonesia

August 01, 2024 06:52 PM AEST | By Cision

Google News:

The Director General of Pharmaceuticals and Medical Devices Visits Fapon in Indonesia — Image source: Kalkine Media

Recent News

Ian Lazar Lifestyle Magazine Confirm Running Features On Specialist Sy...

Rocket Lab Successfully Launches Third Mission for iQPS in Multi-Launc...

'Journey Through Time' is an enlightening exploration of RCIA by Laure...

“Life of Abuse to Success: A Child’s Story” is a poignant memoir of re...

JAKARTA, Indonesia, Aug. 1, 2024 /PRNewswire/ -- The Ministry of Health of the Republic of Indonesia, represented by the Director General of Pharmaceuticals and Medical Devices (Dirjen Falmakes), Dr. Dra. Lucia Rizka Andalucia, along with the Director of Medical Device Production and Distribution Mr. Dede Mulyadi, and the Director of Medical Device Control Mrs. Eka Purnamasari, visited PT Fapon Bioindustries Indonesia (PT Fapon), Fapon's first international manufacturing base outside of China, on July 27, 2024.

PT Fapon is a subsidiary of Fapon, a global leading life sciences company specializes in offering integrated solutions and services for diagnostics, biopharma, and biotherapy. The new manufacturing base, located in Jawa Barat, has been built in adherence to the stringent ISO 14644 standards, setting a new benchmark for In Vitro Diagnostic (IVD) production in Indonesia.

By establishing a world-class facility in Indonesia, PT Fapon is committed to introduce the latest IVD technologies and products to the local market. The new manufacturing base is adept at producing an extensive array of IVD products and solutions tailored for more affordable and accessible IVD needs in Indonesia. PT Fapon aims to leverage its leading IVD technologies and expertise to empower the development of Indonesia's diagnostic capabilities, improve healthcare accessibility, and elevate the overall health and quality of life for the Indonesian people.

During the visit, Dr. Lucia Rizka Andalucia commended PT Fapon for the establishment of a state-of-the-art IVD production facility in Indonesia and its contribution to Indonesia's local content (TKDN). Dr. Lucia expressed high expectations that Indonesians working at Fapon will grasp advanced technologies to support the company's growth. As a model of successful Indonesia-China cooperation in the medical industry, PT Fapon's endeavor is anticipated to encourage further foreign investment in the country's healthcare sector. "We are excited to welcome Fapon's investment in Indonesia," said Dr. Lucia Rizka Andalucia, "Through such strategic alliances, we are poised to cultivate a robust local IVD industry boasting a high TKDN value and meet the rising healthcare needs of the Indonesian population."

"Our new facility in Indonesia marks our long-term commitment to the local market," said Peter Hu, Vice President of Fapon Biotech. " We are honored to further strategic partnership with the MoH to foster extensive and profound cooperation. Fapon aims to collaborate with the Indonesian government and our partners to develop an IVD industrial cluster, enabling the local diagnostic capabilities with our technology and total solutions."

With the establishment of this new production facility, Fapon is dedicated to further propel the development of the IVD industry with local partners.

About Fapon

Fapon is a global leading life sciences company dedicated to providing integrated solutions and services for diagnostics, biopharma and biotherapy. Integrating a one-stop solution on raw materials, reagents and innovative open instrument platforms, the Company has grown into a leading supplier in in-vitro diagnostics. Fapon boasts advanced innovations in therapeutics technologies and AI algorithm platforms with data insights that contribute to a better and healthier world. Supported by its strong global R&D, manufacturing, sales and service network, Fapon's products have established presence in 68 countries and regions, serving more than 2,500 business partners worldwide.

CONTACT: Chen Tina, [email protected]

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.